Arefa MD's Morning Report: Statin-SSRI Combination, Statins in CKD, Warfarin, Exercise

Dr Arefa Cassoobhoy provides a quick rundown of this week's news on statins to augment SSRIs, statins in CKD, warfarin and INR stability, and exercise as prevention.
Source: Medscape Medscape Podcast - Category: Journals (General) Authors: Source Type: podcasts

Related Links:

AbstractEffects of statins over clinical changes in Alzheimer ’s disease (AD) are usually non-significant, but epistatic interactions between genetic variants involved in cholesterol metabolism could be important for such effects. We aimed to investigate whetherLDLR single-nucleotide polymorphisms rs11669576 (LDLR8), rs5930 (LDLR10), and rs5925 (LDLR13) are associated with cognitive and functional changes in AD, while also consideringAPOE haplotypes and lipid-lowering treatment with lipophilic statins for stratification. Consecutive outpatients with late-onset AD were screened with cognitive tests, while caregivers s...
Source: Journal of Molecular Neuroscience - Category: Neuroscience Source Type: research
Conclusions: The present study provides valuable knowledge on the potential benefits of statins in kidney transplant recipients. This meta-analysis shows that statin therapy modifies the lipid profile in this patient population. PMID: 32462035 [PubMed - in process]
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
Conditions:   COVID;   Statin;   Cardiovascular Diseases Intervention:   Drug: observational Sponsor:   Institut Investigacio Sanitaria Pere Virgili Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   COVID;   Statin;   Cardiovascular Diseases Intervention:   Drug: observational Sponsor:   Institut Investigacio Sanitaria Pere Virgili Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   COVID;   Statin;   Cardiovascular Diseases Intervention:   Drug: observational Sponsor:   Institut Investigacio Sanitaria Pere Virgili Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Authors: Facciorusso A, Buccino VR, Tonti P, Sacco R PMID: 32462964 [PubMed - as supplied by publisher]
Source: Expert Review of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Expert Rev Gastroenterol Hepatol Source Type: research
Conclusions and implications of key findings: Pravastatin 40 mg demonstrated the best effect on all-cause mortality, and was observed to be effective with high ranking in cardiac events. We anticipate that the data of this study will assist physicians in making informed decisions when selecting statins, such as pravastatin, as a treatment option for CKD patients.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
[CME/Answers: Familial Hypercholesterolemia - Statin Treatment during Pregnancy and Breastfeeding]. Praxis (Bern 1994). 2020;109(7):546-547 Authors: Shala-Haskaj P, Krähenmann F, Schmidt D PMID: 32456586 [PubMed - in process]
Source: Praxis - Category: General Medicine Authors: Tags: Praxis (Bern 1994) Source Type: research
Four retrospective studies from the United States, Europe, and Asia address outcomes in juvenile myasthenia gravis. Common features include earlier onset with ocular myasthenia gravis (MG) and generally good outcomes overall. Patients who were seronegative, had equivocal acetylcholine receptor (AChR) antibodies, or had only clustered AChR antibodies had better outcomes. An article highlighting the utility of median nerve slow-repetitive stimulation is reviewed and another showing the high sensitivity of repetitive nerve stimulation in myasthenic crisis is covered. Two articles address the thymus and thymectomy in non-AChR ...
Source: Journal of Clinical Neuromuscular Disease - Category: Neurology Tags: Review Article Source Type: research
AbstractIntroductionLipid-lowering therapy of elderly patients with coronary artery disease (CAD) inherits a medical challenge, as these patients experience a higher absolute risk reduction but may be more prone to side effects. We aimed to evaluate the treatment patterns in lipid-lowering therapy, comparing CAD patients above versus below 75  years of age.MethodsWe retrospectively included patients with known CAD admitted to the West German Heart and Vascular Center. Low-density lipoprotein cholesterol (LDL-C) levels and intensity of statin therapy (based on dosage and type of statin) were assessed from all available...
Source: Drugs and Aging - Category: Geriatrics Source Type: research
More News: Cholesterol | Coumadin | General Medicine | Podcasts | Sports Medicine | Statin Therapy | Warfarin